Billing & Reimbursement
GEBT, the only FDA-approved breath test for measuring the rate of solid phase gastric emptying, has an exclusive CPT code for billing and is covered by Medicare.
For any questions regarding insurance and billing please contact us at billing@cairndx.com, or at 615-376-5464, x199.
CPT Code Information
CPT CODE: AMA CPT 0106U
TITLE: 13C-Spirulina Gastric Emptying Breath Test (GEBT)
TYPE OF CODE: CPT Proprietary Laboratory Analysis (PLA) Code
EFFECTIVE DATE: October 1, 2019
CODE DESCRIPTION: Gastric emptying evaluation; Serial collection of 7 timed breath specimens, utilizes Non-radioisotope carbon-13 (13C) Spirulina substrate, Analysis of each specimen by high precision gas isotope ratio mass spectrometry (GIRMS), Reported as rate of 13CO2 excretion (kPCD metric) at each measurement time.
CMS (Medicare) Coverage Information
INTENDED USE POPULATION: Patients age 18+ symptomatic for gastroparesis
COVERAGE DECISION DATES: July 29, 2020
CMS APPROVING BODY: Jurisdictions JJ, JM and MolDx, Palmetto GBA.
BASIS OF APPROVAL: FDA approval and “analytic and clinical validity as well as clinical utility in the evaluation of gastroparesis.”
Fill out the Form Below for Additional Information on
Billing and Reimbursement.
Dedicated to your health, every day
The GEBT should not be used in people with hypersensitivity to Spirulina, egg, milk, or wheat allergens and should not be used in patients with certain lung diseases or small bowel malabsorption. For a complete list of warnings, precautions and contraindications, please see the Package Insert.
Quick Links
Contact Info